Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine mouthwash versus intravenous esketamine for chemotherapy-related oral mucositis pain
NL-OMON60001Phase 2Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of esketamine in stomatitis (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Average oral and pharyngeal pain score at 1 hour after first dose. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
stomatitis
Beyond the preview
Go deeper on NL-OMON60001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60001.